CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
BILOBA is developing a point-of-care platform for real-time cancer biomarker detection using advanced optical techniques. By combining label-free and labeled detection methods, the project aims to enhance sensitivity and reliability in identifying biomarkers associated with cancer progression.
BILOBA aims to develop and pre-clinically validate a multifunctional point-of-care platform capable of performing real-time cancer biomarker detection in a tandem configuration.
The configuration exploits a label-free detection based on the resonance shifts, and the spectral analysis of enhanced fluorescence emitted by biomolecules immobilized on the surface.
Utilizing both labeled and label-free analysis on one sensor increases the sensitivity and the reliability of optically read-out surface b…
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, GROSSROHRSDORF
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
France, VILLEURBANNE
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
France, Palaiseau
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
